MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 105 filers reported holding MEI PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,000 | -93.1% | 4,865 | -90.0% | 0.00% | – |
Q2 2022 | $29,000 | -31.0% | 48,648 | -30.4% | 0.00% | – |
Q1 2022 | $42,000 | -94.0% | 69,904 | -73.4% | 0.00% | – |
Q4 2021 | $702,000 | +475.4% | 263,174 | +494.0% | 0.00% | – |
Q3 2021 | $122,000 | +197.6% | 44,304 | +205.4% | 0.00% | – |
Q2 2021 | $41,000 | -90.2% | 14,506 | -88.1% | 0.00% | – |
Q1 2021 | $418,000 | +141.6% | 121,889 | +85.8% | 0.00% | – |
Q4 2020 | $173,000 | -28.2% | 65,601 | -15.2% | 0.00% | – |
Q3 2020 | $241,000 | -32.9% | 77,403 | -11.1% | 0.00% | – |
Q2 2020 | $359,000 | +290.2% | 87,094 | +53.3% | 0.00% | – |
Q1 2020 | $92,000 | -60.9% | 56,816 | -40.0% | 0.00% | – |
Q4 2019 | $235,000 | +142.3% | 94,731 | +63.5% | 0.00% | – |
Q3 2019 | $97,000 | -44.9% | 57,937 | -17.6% | 0.00% | – |
Q2 2019 | $176,000 | -83.2% | 70,329 | -79.4% | 0.00% | -100.0% |
Q1 2019 | $1,050,000 | +67.5% | 342,163 | +44.0% | 0.00% | – |
Q4 2018 | $627,000 | +486.0% | 237,606 | +858.1% | 0.00% | – |
Q3 2018 | $107,000 | +10600.0% | 24,800 | +16003.9% | 0.00% | – |
Q3 2014 | $1,000 | -80.0% | 154 | -67.2% | 0.00% | – |
Q1 2014 | $5,000 | -94.3% | 470 | -95.7% | 0.00% | – |
Q4 2013 | $87,000 | +480.0% | 10,875 | +688.0% | 0.00% | – |
Q3 2013 | $15,000 | +275.0% | 1,380 | +173.8% | 0.00% | – |
Q2 2013 | $4,000 | – | 504 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|